Abstracts tagged "drug therapy and fibromyalgia"

Abstract Number: 1882 • ACR/ARHP Annual Meeting 2014
Examination of Patients Newly Diagnosed with Fibromyalgia: Use of Guideline-Recommended Therapies and Opioids in Clinical Practice
Sonali N. Shah¹, Rachel Halpern², Joseph C. Cappelleri³, Elizabeth T. Masters⁴, Andrew G. Clair⁵, Cori Blauer-Peterson² and Damon Van Voorhis⁶, ¹Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, ²Health Economics and Outcomes Research, Optum, Eden Prairie, MN, ³Biostatistics, Pfizer, Inc., Groton, CT, ⁴Health Economics and Outcomes Research, Pfizer Inc, New York, NY, ⁵US Medical Affairs Primary Care, Pfizer, Inc., New York, NY, ⁶Optum Life Sciences, Eden Prairie, MN
Background/Purpose: Fibromyalgia (FM) affects 2-5% of adults in the United States. Pregabalin (antiepileptic drug [AED]), and duloxetine and milnacipran (serotonin and norepinephrine reuptake inhibitors), are…